Union Health Minister Mansukh Mandaviya on August 5 said he has held a meeting with Dr. Reddy's Laboratories Chairman Satish Reddy in connection with the production and supply of COVID-19 vaccine Sputnik V. Dr. Reddy's

The meeting was held to discuss the Sputnik V vaccine production and its supply. In a tweet, Mandaviya said, " I held a meeting with Dr. Satish Reddy, Chairman of Dr. Reddys Lab and had a discussion on the production of the Sputnik V COVID-19 vaccine and its supply".

Mandaviya earlier on August 3 informed Parliament that four more Indian pharmaceutical companies may start vaccine production by October-November to accelerate the inoculation drive. He had said, "Two companies namely Bharat Biotech and Serum Institute, are supplying the vaccines to the government. Sputnik vaccine is also available, production of which has begun".

Notably, Dr. Reddy has tied up with the Russian Direct Investment Fund for Sputnik V production in India and launched the vaccine here in May 2021, after receiving Emergency Use Authorization in April 2021. Along with Dr Reddy's, the Russian Direct Investment Fund (RDIF) has tied up with six Indian drug makers for Sputnik V vaccine production in India.

Latest corona cases update in Arunachal Pradesh and Puducherry

Relief for Gautam Adani, Modi govt given 90 days for this work

Will discussions resolve Assam-Mizoram border dispute?